News Hub | News Direct

Meet Your New Coworker: A Humanoid Robot Named Apollo

MarketJar

Austin-based tech startup Apptronik just unveiled Apollo, a humanoid robot designed to transform the industrial workforce. Standing at 5 feet, 8 inches tall, and weighing 160 pounds, Apollo has the ability to lift 55 pounds and is designed to perform menial tasks in the logistics and manufacturing industries. According to co-founder and CEO of Apptronik Jeff Cardenas, we need to fundamentally change the way we think about work, particularly in the warehouse and the supply chain, as labor challenges and employment trends continue to impact our economy. "People don't want to do robotic, physically demanding work in tough conditions and they shouldn't have to. Humanoid robots are not just an answer to this challenge, they are a necessity – and because of our deep robotics lineage, Apollo is uniquely positioned to quite literally step in and make an impact," he added. While Apptronik's initial focus is on case and tote handling solutions in the logistics and manufacturing industries, the company said Apollo is a general-purpose robot designed to work in the real world with the ability to eventually move into construction, oil and gas, electronics production, retail, home delivery, elder care, and countless other industries. Ash Sharma, Managing Director at Interact Analysis, highlighted the burgeoning demand for robotic solutions in logistics due to labor shortages, noting that billions are being invested to implement robots to help pick, move, and sort goods through warehouses across the world. According to a Goldman Sachs report published last November, humanoid robots could be economically viable in warehouse settings between 2025 and 2028 and in consumer applications between 2030 and 2035. Spearheading the Rise of Autonomous Security Robots In the battle against escalating crime rates, technology presents an avenue to bolster safety and security. While humanoid robots like Apollo are groundbreaking, security robots are carving their niche, promising to be a robust deterrent against crime. It's expected that by 2030, the global security robot market will skyrocket to an estimated $31.08 billion, with an impressive compound annual growth rate of 12.8%. At the helm of this transformative movement is Silicon Valley-based Knightscope, Inc. (NASDAQ:KSCP). Founded in 2013, Knightscope stands as a testament to the fusion of autonomy, robotics, artificial intelligence, and electric vehicle technology. Their autonomous security robots (ASRs) serve a simple yet vital purpose: deter, detect, and report. With an astounding 2.3 million hours under its belt in real-world operations, Knightscope's tech prowess has been proven in the field The acquisition of CASE Emergency Systems in 2022 marked a pivotal moment for Knightscope. This move not only amplified the company’s capabilities but also brought in significant revenue growth. The company boasts an impressive clientele, including the New York Police Department (NYPD), New York City Fire Department (FDNY) and the Orange County Transportation Authority (OCTA). Throughout the year, Knightscope secured several substantial deals, including a $1.25 million contract for 145 devices with Rutgers, The State University of New Jersey; a pilot contract with the New York Police Department (NYPD) for a K5 robot designated for patrolling a Manhattan subway station. Another significant achievement was the successful deployment of Knightscope 's first two K1 Hemisphere ASRs in Hawaii. This deployment marks the end of the product development process—client testing. Knightscope has begun a rigorous evaluation process in collaboration with a globally recognized brand specializing in full-service hotels and resorts. The deployment of a K5 in Ohio has attracted national attention, further demonstrating the company's influence and establishing Knightscope 's position as a significant participant in the growing field of security technology. Underpinning their successes is the vision and leadership of Knightscope CEO, William Santana Li. His optimism was palpable during the 2Q 2023 update, where he shared, “In the first six months of 2023, we've reported a revenue of $6.4 million. This projects an over $12 million annual revenue, doubling our figures from the previous year. The Rise of the Robots is not a future prospect—it's our reality.” To delve deeper into Knightscope 's innovations and projects, readers can visit the provided link or explore the ' Rise of the Robots ' on Knightscope's official website. Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Knightscope, Inc. Market Jar Media Inc. has or expects to receive from Knightscope, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) two hundred and sixty-six thousand USD for 89 days (63 business days). 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management’s expectations regarding Knightscope, Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Knightscope, Inc.’s industry; (b) market opportunity; (c) Knightscope, Inc.’s business plans and strategies; (d) services that Knightscope, Inc. intends to offer; (e) Knightscope, Inc.’s milestone projections and targets; (f) Knightscope, Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Knightscope, Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Knightscope, Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Knightscope, Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Knightscope, Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Knightscope, Inc.’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) Knightscope, Inc.’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Knightscope, Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Knightscope, Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Knightscope, Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Knightscope, Inc.’s business operations (e) Knightscope, Inc. may be unable to implement its growth strategy; and (f) increased competition.Except as required by law, Knightscope, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Knightscope, Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Knightscope, Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Knightscope, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Knightscope, Inc. or such entities and are not necessarily indicative of future performance of Knightscope, Inc. or such entities. 8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

September 06, 2023 01:31 PM Eastern Daylight Time

Image

10 Reasons You May Want To Have Mainz Biomed (NASDAQ: MYNZ) On Your Radar

Benzinga

By Faith Ashmore, Benzinga The WHO reports that colorectal cancer is the second most fatal cancer around the world. However, it is also the most preventable, with early detection leading to survival rates above 90%. Alarming statistics reveal that new cases of colorectal cancer in individuals under the age of 50 have been steadily rising over the past few decades. Colorectal cancer is now the leading cause of cancer death for Americans between the ages of 20 and 59 years old according to the National Cancer Institute. However, younger adults are not routinely screened for colorectal cancer as it is still relatively uncommon in their age group. Mainz Biomed (NASDAQ: MYNZ), a company that specializes in developing molecular genetic diagnostic solutions for life-threatening conditions, has created ColoAlert, an innovative product that addresses the need for easier and more accessible cancer screenings for quick detection and treatment of colorectal cancer. This non-invasive and user-friendly test aims to make colorectal cancer screening fast, simple and precise. The company seems to be gaining momentum in the industry, and here are 10 reasons you may want to keep your eye on them. Flagship Product For Early Detection Mainz Biomed has developed a flagship product, ColoAlert, which has the potential to establish the company as a frontrunner in the early detection of colorectal cancer. By providing a highly sensitive and accurate screening tool, ColoAlert has the capacity to revolutionize the way colorectal cancer is detected and treated. The test is the first DNA-based screening test for colorectal cancer in Europe, which sees the highest incidence rate for colorectal cancer. Tapping into A Multi-Billion Dollar Market While this innovative screening tool will be useful to young people who don’t get regular screenings, is not limited to younger ages. In fact, ColoAlert may have an annual market opportunity of around $3.7 Billion in the U.S. for testing populations aged 50 and above every three years, as recommended by the FDA. ColoAlert's unique genetic profiles allow for tailored treatment for each individual patient, leading to better health outcomes for patients with colorectal cancer. This revolutionary product is a major stride in combating colorectal cancer and has the potential to save countless lives. As GenX individuals age into their 40s and 50s, they become part of the age group recommended for colorectal cancer screening. This demographic shift presents a significant market opportunity as the demand for screening and related services continues to rise. Experienced Leadership Team Mainz Biomed has successfully attracted former executives from major pharmaceutical giants to its leadership team. CEO Guido Baechler, a former Roche Molecular Diagnostics executive, brings invaluable expertise to the company's strategic development. Additionally, Chief Commercial Officer Darin Leigh's extensive executive commercial experience across leading life science and healthcare firms further strengthens the company’s leadership. Positive Feedback And Upcoming Studies Mainz Biomed has already received encouraging feedback for its lead product, ColoAlert. This feedback serves as an endorsement of the product's effectiveness and potential impact on early detection. Furthermore, the company expects upcoming study data to validate the clinical benefits and efficacy of ColoAlert, further bolstering its role as an essential tool in colorectal cancer screening. Detecting Precancerous Conditions The company's focus on detecting advanced adenoma represents a significant stride in identifying colorectal cancer at a precancerous stage. By identifying and removing these precursors during screening, Mainz Biomed helps prevent the progression of the disease and reduces the risk of developing colorectal cancer. This early intervention can have a profound impact on patient outcomes and survival rates. Strong Price Target Analysts have set an $11 price target for MYNZ, reflecting the positive sentiment surrounding the company's growth potential. This price target implies confidence in Mainz Biomed’s ability to capture a significant share of the market and generate value for investors. The company has seen significant revenue growth in 2023 -- the revenues generated by ColoAlert in the first half of 2023 surged by 108% when compared to the same period in 2022 as the company expanded international commercialization for ColoAlert and entered new markets in Europe. This remarkable growth further solidifies Mainz Biomed's position in the industry and showcases its ability to develop groundbreaking products that meet the needs of healthcare professionals and patients alike. Flagship Product Competes With Large Players Mainz Biomed's ColoAlert competes with Cologuard from Exact Sciences Corporation (NASDAQ: EXAS), a well-established company that commands a market cap of over $10 billion. It’s clear that even in the earlier stages, Mainz Biomed is shaping up to be a formidable player in the field of early detection for colorectal cancer. Expanding International Presence The company is actively pursuing international commercial activities to introduce ColoAlert to a global market. By expanding its reach, it aims to increase accessibility to its innovative screening product, ensuring early detection and prevention of colorectal cancer on a global scale. Strong Financial Position The company also boasts of a stable financial position due to ample cash reserves, enabling the company to fund ongoing operations and drive growth initiatives effectively. In June, the company secured up to $50 million in new funding. This financial strength provides Mainz Biomed with the stability and resources necessary to invest in research and development, expand its portfolio and bring innovative products to market. Strategic Partnership For Novel Biomarkers The company has established a strategic partnership with Microba Life Sciences to explore the discovery and integration of novel microbiome biomarkers into its pipeline asset, PancAlert. By leveraging Microba's expertise, the company aims to develop PancAlert into a potential first-in-class screening test for pancreatic cancer, addressing a critical need for early detection of this challenging disease. The Future For Mainz Biomed And Cancer Diagnostics Mainz Biomed is on a mission to become a leading global provider of easy-to-use diagnostic solutions for patients and healthcare providers everywhere. The company heads into the second half of 2023 confident of future growth as ColoAlert gains more traction in Europe and select international markets. The company also has a busy pipeline. It is ramping up enrollment planning for ReconAAsense – the company’s U.S. pivotal study for its flagship product – and executing clinical trials evaluating a portfolio of proprietary novel gene expression (mRNA) biomarkers for potential inclusion into ReconAAsense. Through its partnership with Microba Life Sciences, Mainz is also advancing PancAlert, its next-generation pancreatic cancer detection test. Interested investors may want to watch out for data from the company’s two feasibility studies. With a combination of innovative products, experienced leadership, an active pipeline and strategic collaborations, Mainz Biomed seems well-positioned to make a significant impact on the early detection of colorectal and potentially other markets like pancreatic cancers. Their commitment to pushing the boundaries of diagnostic technology and growth trajectory seems to be making them a force to be reckoned with in the industry, setting them apart from their competitors. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 06, 2023 09:25 AM Eastern Daylight Time

Octane11 Introduces the "B2B Marketing Impact Audit”

Octane11

Octane11, the B2B marketing analytics platform known for its industry-leading integration of marketing and sales data, announced today the release of its new product: the Octane11 B2B Marketing Impact Audit. The B2B Marketing Impact Audit will revolutionize the way B2B companies assess, plan, and optimize their marketing and sales tactics. "We recommend Octane11’s B2B Marketing Impact Audit for all of our clients. It’s remarkably powerful with a fast and seamless set up,” said Scott Stedman, CEO of The Imaginarium. “It offers a ‘set it and forget it’ experience that delivers a concise yet comprehensive analysis of valuable insights in just 30 days, empowering our clients to ensure that their marketing engine is driving maximum revenue growth.” As marketers continue to navigate uncertain economic times and lean budgets, the B2B Marketing Impact Audit enables B2B CMOs to enhance year-end performance and make informed investment decisions for the upcoming year. The end-to-end analysis across paid, owned, and earned marketing tools and the sales CRM, provides a holistic and in-depth view of existing marketing expenditures and performance, which is especially critical as businesses strategize to invest wisely amidst this unpredictable macroeconomic environment. Delivering Proven Value to Marketer s Fast and Easy Setup: Octane11’s team of experts guide businesses through setup in four live sessions, ensuring data quality and completeness. The Audit then runs in the background for thirty (30) days. Unified Scorecard: The Audit produces a summary scorecard featuring 20 critical KPIs including ROI, Cost-per-Lead, and % of Target Accounts Engaged; marketers also receive performance comparisons against industry peers and a clear letter grade, highlighting key areas for immediate improvement. Comprehensive Analysis: The Audit includes 15 pages of clear visualizations and expert analysis, including practical and tangible recommendations on effective budgeting, tactic optimization and growth acceleration through incremental, Octane11-certified strategies. Industry Benchmarks: Company data is benchmarked against a range of B2B peers, enabling marketers to contextualize their performance with real-world comparisons updated quarterly as market conditions and the vendor landscape evolve. Interactive Access: Clients also receive access to live dashboard views, enabling them to dive deeper into the information through drill downs and scenarios, share findings with colleagues, and export data into CRM or BI platforms. Data Health and Alignment: The Audit also identifies anomalies in data setup and flags any misalignment between the marketing and sales teams’ objectives. Data Protection: The Audit is SOC2-compliant and utilized by leading privacy-focused Fortune 500 clients. It also provides the option to omit PII at the clients’ request. For a deeper dive into the features and benefits of the B2B Marketing Stack Audit, please visit www.octane11.com/audit. About Octane11 Octane11 is a B2B-focused data analytics and collaboration platform that connects paid, owned, and earned marketing, sales, and product usage data to drive real business results. We help B2B enterprises with $100M+ in revenue to integrate, enrich, and analyze data across teams, and compare performance to industry benchmarks. Octane11 is backed by Javelin Venture Partners, BDMI, Honeystone Ventures, Circadian Ventures, Plug and Play Ventures, Base Ventures, and AperiamVentures. Launched in 2020, Octane11 is already helping some of the largest B2B enterprises break down data silos and turn every digital interaction into an actionable insight. To learn more, visit www.octane11.com and follow us on LinkedIn. For media inquiries and more information, contact: press@octane11.com Contact Details Octane11 Press Inquiries +1 646-397-1631 press@octane11.com Company Website http://www.octane11.com

September 06, 2023 09:05 AM Eastern Daylight Time

Quantum Software Leader Classiq Expands to Boston, Relocates Key Executive to Build Out North American Presence

Classiq Technologies

Classiq Technologies, a leading quantum computing software company, today announced its expansion into the Boston area and the relocation of Shai Lev, vice president of strategic partnerships, to lead the company's growth in North America. Headquartered in Tel Aviv, Classiq has seen rapid growth over the past year as demand increases for its quantum computing software. The company's expansion into Boston enables it to tap into the region's bustling quantum ecosystem, renowned academic institutions and key industries pursuing quantum applications. "As we continue our impressive momentum helping organizations develop real-world quantum applications, Boston is a clear choice for further expansion," said Nir Minerbi, CEO and co-founder of Classiq. "The Boston area is a hub for quantum research and education with an incredible pool of quantum talent. Industries aggressively exploring quantum's potential, such as financial services, pharmaceuticals and healthcare, are very strong there." Lev has been instrumental in forging partnerships with leading quantum hardware and software companies. To lead Classiq’s North America expansion, he relocated and will open the company's Boston-area office. "Boston has one of the highest concentrations of quantum activity today – from research at MIT, Harvard and other universities, to government-funded programs and private-sector efforts," said Lev. "It’s exciting to represent Classiq in the Boston ecosystem and throughout North America as we introduce more organizations to our technologies and products to accelerate their journey to quantum advantage." About Classiq Classiq Technologies, the leading quantum software company, provides an all-encompassing software platform with a single point of entry into quantum computing, from algorithm design to execution. Tailored to all levels of developer proficiency, Classiq aims to democratize access to quantum computing with software that equips customers to take full advantage of the quantum computing revolution. A low-code development environment ensures that a broader range of talents, including those with backgrounds in AI, ML and linear algebra, can harness quantum computing without requiring deep, specialized knowledge of how to program quantum computer hardware. Backed by powerful investors such as HPE, HSBC, Samsung, Intesa Sanpaolo and NTT, Classiq’s world-class team of scientists and engineers has distilled decades of quantum expertise into its groundbreaking software development platform. Follow Classiq on LinkedIn, X (formerly Twitter), or YouTube, or visit www.classiq.io to learn more. Contact Details Rainier Communications Michelle Allard McMahon/Jenna Beaucage classiqPR@rainierco.com Company Website http://www.classiq.io/

September 06, 2023 08:05 AM Eastern Daylight Time

Logitix Names Live Entertainment Executive Wendi Rohan Lebow as Vice President of Open Distribution

Logitix

Logitix, a leader in live event ticketing technology and analytics, announced it has named Wendi Rohan Lebow as Vice President of Open Distribution. Lebow will oversee Logitix’s proprietary technology, Open Distribution, which allows venues and live event companies to distribute, price, and sell their primary ticket inventory across multiple integrated marketplaces that Logitix utilizes. Lebow’s extensive live entertainment experience includes leadership roles at TodayTix Group and Goldstar Events, Inc. Lebow’s role as Vice President of Open Distribution is a newly created position for Logitix, which works with venues and live event companies across the performing arts, music, and sports. As an innovative product that is changing how the industry sells and distributes tickets, Open Distribution by Logitix is a native integration with the organization’s primary ticketing system that allows designated tickets to be listed on the primary and secondary channels at the same time. The technology leverages the primary ticketing system’s native fulfillment methods, ensuring the fan gets their ticket and the venue obtains customer information seamlessly. At Logitix, Lebow will work cross-functionally with Logitix’s product, marketing, operations, and business development, in addition to collaborating with external partners to optimize the use of Open Distribution. “The demand and interest in our Open Distribution product from across the live event industry is skyrocketing daily, and the need for a top-tier executive to lead this area for us became clear,” said Logitix CEO Stu Halberg. “We are fortunate to have Wendi join our leadership team. She is a well-respected ticketing professional who has helped thousands of brands sell millions of tickets throughout her career.” “I’ve had the opportunity to partner with Wendi and her team when I was at Tessitura and she was leading venue partnerships for Goldstar,” said Logitix Strategic Advisor Jack Rubin, the Co-Founder and former CEO of Tessitura Network. “Wendi’s experience with distribution technologies, especially in the performing arts industry, is world-class. She is a tremendous addition to the Logitix team who understands the sectors served and will help the organizations create revenue. I look forward to working with her and building on the success created to date.” Lebow led venue relations and partnerships for Goldstar Events, Inc. for 15 years, rising to the position of Chief Venue Officer. Goldstar was acquired by TodayTix Group in 2021 when Lebow transitioned to the role of Vice President of Partnerships North America, a position that she held for the last year and a half. Earlier in her career, she worked with TMG – The Marketing Group, where she managed marketing and promotions for Broadway shows in New York and Los Angeles. She earned her BFA in Musical Theatre from the Cincinnati Conservatory of Music. About Logitix Logitix is the preeminent monetization engine and ticketing platform for the live event industry, combining optimized pricing, distribution, and inventory management with real-time insights to help sellers and buyers respond to a rapidly changing market environment. The Logitix vision is to automate the entire ticket life cycle and provide data-driven insights to serve the diverse needs of its clients. The company is backed by ZMC and is privately held. For more information about Logitix, visit Logitix.com or find them on LinkedIn. Contact Details Eric Nemeth +1 602-502-2793 nemeth@ericpr.com Company Website https://logitix.com/

September 06, 2023 07:45 AM Eastern Daylight Time

Blackbird Creator SaaS product now "very close to early access"

Blackbird PLC

Blackbird PLC (AIM:BIRD, OTCQX:BBRDF) CEO Ian McDonough speaks to Proactive's Thomas Warner after the technology company published its interim results for the first half of 2023. Blackbird posted a 36% year-on-year drop in revenues in H1 2023 owing to the receipt of EVS development fees and the revenues from the global winter games during H1 2022. McDonough emphasises that the company's focus has shifted towards the development of their Creator SaaS product. This product is set for an early access release in the coming months and is poised to enter the market fully in Q1 next year, potentially bringing in revenue. McDonough sees this new product as a significant step toward diversification. While their existing technology has excelled in prestigious events like the Super Bowl and the Women's World Cup, the new platform aims to cater to a broader audience, offering high availability, a SaaS model, and ease of access. McDonough also highlighted their world-class team, strategic planning since 2019, and the successful funding round in 2021, all culminating in a keenly-awaited product launch scheduled for Q1 2024. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

September 06, 2023 06:11 AM Eastern Daylight Time

Video

Harvest Thermal Builds Leadership Team

Harvest Thermal

Harvest Thermal, the technology company redesigning home heating, cooling, and hot water for a livable planet set the stage for accelerated growth by hiring two accomplished professionals to its executive team. The award-winning Bay Area start-up appointed Matthew Lacey as Vice President of Sales and Trent Wolbe as Vice President of Marketing. These strategic hires deepen Harvest’s commitment to delivering extraordinary climate impact with its smart thermal battery that lowers operating costs, slashes emissions, and enables building electrification at scale. With over 16 years of sales leadership experience in the HVAC industry, Mr. Lacey has a proven track record of driving revenue growth recently at Samsung HVAC and Daikin North America. At Daikin, Mr. Lacey launched new products that today are volume leaders in the company’s mini-split, ductless and multi-zone categories. He’s most proud of building teams that have won numerous sales awards, in one case doubling sales in three years. Notably, Mr. Lacey served with distinction in the US Army during the Gulf War era where he won numerous awards and earned the respect of his commanding officers. While serving in Egypt, Mr. Lacey was nicknamed “Witch Doctor” and was celebrated for his ability to fix aircraft that were considered too broken to fly, helping his battalion achieve greater efficiencies, readiness, and battlefield effectiveness. His time in the military instilled in him a strong sense of discipline, teamwork, and strategic thinking that will greatly benefit Harvest’s sales division. To lead its Marketing Department, Harvest Thermal tapped Mr. Wolbe after he led sustainability at global events for Google. Mr. Wolbe pushed the envelope in decarbonizing Google’s most high-profile events, meeting high standards of sustainability while enhancing attendee experiences. Rooted in journalism, broadcasting, and podcasting, Mr. Wolbe leverages social science and storytelling to connect with audiences and inspire climate action. As Creative Director at Optimist Inc., he worked with some of the world's largest retail brands (Nike, H&M) to create fun, futuristic, and emotional content that drove authentic experiences and enhanced brand value. Mr. Wolbe is super-excited to help evolve and evangelize the Harvest Thermal brand as it ascends to its next level of growth and impact. "We are delighted to welcome Matt and Trent to our executive team," said Jane Melia, CEO and Co-founder of Harvest Thermal. "They bring exceptional talent, proven leadership, and deep knowledge of their respective fields to our growing company. Their entrepreneurial spirit and dedication to excellence make them invaluable assets as we scale our category-busting smart thermal battery heating and hot water system.” The appointments of Mr. Lacey and Mr. Wolbe come at an exciting time for Harvest Thermal. As it decarbonizes homes, it continues to receive the highest customer satisfaction ratings, expand its product offerings, and build brand value. By strengthening both the sales and marketing teams, the company aims to foster greater synergy between these critical functions, enhance its customer engagement, and deliver greater value to its investors. ABOUT HARVEST THERMAL Harvest Thermal is redesigning home heating, cooling, and hot water for the planet. Its smart thermal battery system cuts carbon emissions by 90% from home heating and hot water compared to gas and 50% compared to heat pumps without storage. The cloud-connected Harvest Pod leverages machine learning software, sensors, and controls to reduce carbon emissions and save on monthly heating bills. It also supports a cleaner, cheaper, and more resilient grid. Founded in 2019, Harvest Thermal has received support from the National Science Foundation, the California Energy Commission, Peninsula Clean Energy, and leading private investors. In 2023, Harvest Thermal was named to Fast Company’s Most Innovative Companies list; awarded NREL Industry Growth Forum’s People’s Choice Award; and won a Silver Edison Award for Sustainable Design in the category Consumer Solutions. Contact Details Harvest Thermal David Tuft +1 202-494-0813 david@harvest-thermal.com Company Website https://www.harvest-thermal.com/

September 05, 2023 08:11 AM Pacific Daylight Time

Image

Technology Touchdown: The Denver Broncos Score Big with Comcast Business

Comcast Colorado

Comcast Business today announced that it is providing the Denver Broncos with a suite of network solutions to help the sports franchise run its operations smoothly – whether it’s a game day or a training day – as well as keep fans connected to their favorite technology-enabled applications when they attend a game at Empower Field at Mile High. Whether it’s managing the plethora of merchandise sales, replaying nail-biting tackles on stadium screens, or asking Miles, the Broncos’ virtual assistant, a question during a game, employees and guests alike can expect reliable experiences backed by Comcast Business. Technology continues to revolutionize the sports industry, transforming experiences for fans and the operations of teams like the Broncos. Fans now expect real-time viewing experiences – regardless of whether they’re in the stadium or watching at home – and are actively participating in gamedays through social media engagement and personalized streaming services. On the backend, technology has ushered in new revenue streams for sports organizations through e-commerce platforms and digital ticketing and point-of-sale applications, and has made it easier to analyze players’ performances during training or game days. All these technology-driven offerings require a strong and reliable network backbone to make them a reality. Solutions provided by Comcast Business include SIP Trunking, between Empower Field at Mile High and the Centura Health Training Center. Additionally, Comcast Business is providing two 10 gig ethernet circuits and Comcast Business Hospitality HD Video for thousands of screens at Empower Field at Mile High. “When it comes to football, players and fans alike know that every second counts, and the same holds true for the technology within sports facilities – if it isn’t fast and reliable, fans and athletes could miss out on exciting experiences,” said Robert Thompson, vice president of business services for Comcast’s Mountain West Region. “We are proud to support the Broncos with technology solutions that not only assist the team’s employees as they work hard to bring these experiences to the Denver community, but that keep fans connected and engaged with the Broncos.” Comcast Business is the Broncos’ main internet provider for employees, players, staff, and media that attend game days. In addition to supporting stadium operations, the 10 gig circuits power the Broncos TV studio to quickly capture and create real-time content – like player interviews, commentator segments, or fan giveaways within the stadium – then broadcast it on TV screens across Empower Field at Mile High. SIP trunking provides reliable phone lines. The strong network backbone created by the combination of these solutions ultimately contributes to a more connected and convenient game day experience for fans, as well as fast, reliable back-end operations for staff. Between 2008 and today, the Broncos have seen its network of connectivity solutions and devices grow exponentially, going from roughly 400 devices supported on its network to 8,000. Despite this growth, the organization’s goal has remained the same – to deliver an uninterrupted technology experience for fans and Broncos staff. By partnering with Comcast Business, the Broncos ensured that its network was flexible, and capable of handling future growth as the sporting industry continues to evolve. “We need to make sure that our back-end network can provide it all, and Comcast Business has created a runway for us that helps ensure our daily operations will be successful,” said Russ Trainor, senior vice president of IT for the Broncos. “We trust Comcast Business to deliver the solutions and support we need every day, not just on game days. And, as we add more services to our existing network, we know Comcast Business will help us deliver them.” In the Denver area, Comcast Business also supports the Colorado Rockies at Coors Field with an enhanced network infrastructure and end-to-end network management solutions. Additionally, in December 2022, Comcast expanded its network throughout the Denver Metro Area, launching an additional multi-gig internet speed tier for Xfinity and Comcast Business customers. The upgrade is delivering download speeds up to two gigabits-per-second and up to 5x to 10x faster upload speeds to customers in select areas. About Comcast Business Comcast Business offers a broad suite of technology solutions to keep businesses of all sizes ready for what’s next. With a range of offerings including connectivity, secure networking, advanced cybersecurity, and unified communications solutions, Comcast Business is partnering with business and technology leaders across industries and integrating Masergy, a leader in software defined networking, to help drive businesses forward. Backed by a next-generation network, Comcast Business has been recognized for its growth, innovation, and leadership in global secure networking. For more information, call 800-501-6000. Follow on Twitter @ComcastBusiness and on other social media networks at http://business.comcast.com/social. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company that connects people to moments that matter. We are principally focused on connectivity, aggregation, and streaming with 57 million customer relationships across the United States and Europe. We deliver broadband, wireless, and video through our Xfinity, Comcast Business, and Sky brands; create, distribute, and stream leading entertainment, sports, and news through Universal Filmed Entertainment Group, Universal Studio Group, Sky Studios, the NBC and Telemundo broadcast networks, multiple cable networks, Peacock, NBCUniversal News Group, NBC Sports, Sky News, and Sky Sports; and provide memorable experiences at Universal Parks and Resorts in the United States and Asia. Visit www.comcastcorporation.com for more information. Contact Details Matt Helmke +1 215-286-8666 matt_helmke@comcast.com Company Website https://colorado.comcast.com/

September 05, 2023 08:00 AM Mountain Daylight Time

The Cultivated B and denovoMATRIX Partner to Bring Cultivated Meat to Commercial-Scale Production Volumes

The Cultivated B

The Cultivated B (TCB) and denovoMATRIX have entered into a collaborative partnership to conduct a feasibility study with implications that enable the scalable, economically viable commercial production of cultivated meats. denovoMATRIX will contribute its microcarrier technology to test the proliferation of suspended cells in TCB’s bioreactors and cell mediums, and its coating technology for functionalizing scaffolding, which enables a structured final cultivated meat product. Cells, by nature, grow by adhering to a surface, inherently limiting cell growth to the surface area of the culture vessel. Microcarriers add surface area to the cell culture while simultaneously ensuring that every cell is sufficiently nurtured to further proliferate while they comfortably float freely. Microcarriers act as an adherence mechanism for cells, contributing to rapid cell doubling and overcoming growth limits. Use of microcarriers will allow industrial-scale cell mass production and establishes a controllable, consistent as well as repeatable pilot-phase process for manufacturing cell mass. This development would set a standard for the industry, enabling traditional meat companies to create and scale their own cultivated meat programs internally. "Together with denovoMATRIX, we're poised to bring our shared vision of a more sustainable, future-forward biotech sector to life," said Dr. Hamid Noori, CEO of The Cultivated B. "This collaboration not only signifies a step forward in cell line technology but also reflects our mutual dedication to progressive innovation in the cultivated meat sector." The collaboration leverages the exclusive and shared technical competencies of the two innovative German B2B technology providers to perform an in-depth analysis of the viability and potential benefits of this integrated system. This synergy will enable an end-to-end approach for the alternative protein sector. denovoMATRIX is contributing its biomaterials, as well as cell biology and development expertise, which has the potential to unlock cell growth/manufacturing opportunities for TCB's cell lines and bioreactor setups. Once the feasibility study concludes and demonstrates productive outcomes, TCB intends to integrate denovoMATRIX technology into its product offerings, marking a major stride in cellular agriculture innovation. Dr. Dejan Hušman, CEO of denovoMATRIX commented, "Our alliance with The Cultivated B is a commitment to enabling existing as well as new players in the cultivated meat space. The outcome which we strive for is a turnkey solution for customers, composed of the expertise and technologies of our two companies." The potential impact of this partnership extends beyond the commercial cultivated meat sector. With the anticipated success of the pilot-phase process, it could be adopted by academic institutions researching cultivated meat, democratizing the initiation of pilot-scale cell manufacturing. About The Cultivated B (TCB) The Cultivated B’s multinational team of scientists develops and applies breakthrough technologies in cellular agriculture, precision fermentation and advanced bioreactor technology to enable scalable commercialization of the cellular-agriculture industry. TCB serves startups, corporations and academic research institutions within the food, pharma, cosmetics and personal care industries. With its pioneering engineering and production capabilities, TCB enables other companies to produce alternative proteins, such as cultivated meat, at industrial scale. The company’s fundamental commitment to minimizing the natural resources used paves the way toward a sustainable future, locally, regionally and globally. TCB’s research and development team is based in Germany, with manufacturing and an innovation hub based in Canada’s Toronto region. For more information, visit https://www.thecultivatedb.com and follow the company on LinkedIn. About denovoMATRIX denovoMATRIX serves customers in cell therapy, cultivated meat and pharmaceutical research with tools for supporting cell isolation, manufacturing, and differentiation. Our offering is focused in three areas, including tailored biomaterials based on our proprietary platform, stem cell biology & characterization services, and finally high potency cell lines. For more information, visit: https://www.denovomatrix.com/ Contact Details The Cultivated B Jenna Beaucage +1 508-340-6851 tcb@rainerco.com Company Website https://www.thecultivatedb.com

September 05, 2023 08:04 AM Eastern Daylight Time

Image